Diabetes Remission in the Alliance of Randomized trials of Medicine versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D)
Kirwan JP, Courcoulas AP, Cummings DE, et al.
Diabetes Care. dc212441
Leggi
Breaking news
Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction
Mone P, Lombardi A, Gambardella J, et al.
Diabetes Care. dc212434
Leggi
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts
Ruiz PLD, Chen L, Morton JI, et al.
Diabetologia. Pub online 22 March 2022
Leggi
The effectiveness of a structured group education programme for people with established type 2 diabetes in a multi-ethnic population in primary care: a cluster randomised trial
Dallosso H, Mandalia P, Gray LJ, et al.
NMCD. Pub online 23 March 2022
Leggi
Mineralocorticoid receptor antagonists and empagliflozin in patients with heart failure and preserved ejection fraction
Ferreira JP, Butler J, Zannad F, et al.
J Am Coll Cardiol. 2022;79(12):1129-37
Leggi
Risks and burdens of incident diabetes in long COVID: a cohort study
Xie Y, Al-Aly Z
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00044-4.
Leggi
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT
Jacob P, Potts L, Maclean RH, et al.
Diabetologia. 2022;1-13
Leggi
Incidence of newly diagnosed diabetes after Covid-19
Rathmann W, Kuss O, Kostev K
Diabetologia. Pub. online 16 March 2022.
Leggi
Current status and emerging options for automated insulin delivery systems
Forlenza GP, Lal RA
Diabetes Technol Ther. Pub. online 14 March 2022.
Leggi
Assessment of glycaemic status in adult hospital patients for the detection of undiagnosed diabetes mellitus: A systematic review
Thornton-Swan TD, Armitage LC, Curtis AM, Farmer AJ
Diabet Med. 2022 Apr;39(4):e14777
Leggi